Skip to content
Search AI Powered
Human content, AI powered search.

Latest Stories

VA Rejects New Cannabis Research Bill For Veterans, Calls It 'Redundant'

Does the VA know what its doing on cannabis policy?
Does the VA know what its doing on cannabis policy?
Photo by Jessica Radanavong on Unsplash
Bluntness Editorial
By Bluntness EditorialJun 29, 2021
Bluntness Editorial
The Bluntness Editorial Staff is dedicated to bring you the many stories of cannabis culture - stories that speak to the enthusiast and expert in an unfiltered but factual manner. Everyday, our writers brings you deeply insightful and honest perspectives from all corners of the cannabis world, including some you may not expect.
See Full Bio
Follow:

This article was originally published by Nina Zdinjak on Benzinga and appears here with permission.

The Senate Veterans’ Affairs Committee reviewed a bill that would ask the U.S. Department of Veterans Affairs (VA) to run clinical trials on the potential benefits of cannabis for the treatment of military veterans suffering from post-traumatic stress disorder (PTSD) and chronic pain. 

The measure, sponsored by chairman Jon Tester (D-MT) and Sen. Dan Sullivan (R-AK), was discussed along with another 20 veteran-related bills although only the cannabis measure was not openly discussed but rather received written testimony opposing it, reported Marijuana Moment. 

Is The VA Against Cannabis Research For Veterans? 

Although VA Acting Deputy Under Secretary of Health for Community Care Mark Upton said the agency does not support this proposed legislation, it is not against cannabis research for veterans in general. 

Nevertheless, the VA seems to find the new legislation to be redundant and therefore unnecessary. 

As stated in testimony: “The proposed legislation is redundant to the extent that VA is already examining risks and benefits of cannabis in treating PTSD and chronic pain. For these reasons, VA does not support this proposed legislation.”

The agency also specifically argued against the provision that would require it to study “at least seven types of cannabis,” a task the VA finds inconsistent with "the current state of scientific evidence, which suggests that smaller, early phase, controlled clinical trials with a focused set of specific aims are optimal to determine proof of concept for use of cannabis in treating specific conditions.”

Upton wrote that the VA continues to research existing clinical evidence on the medical benefits of cannabis and acknowledges that more research is necessary.

 “VA has utilized the scientific peer review system and is currently supporting a clinical trial of CBD to treat PTSD where CBD is used as an add-on treatment to standard of care psychotherapy. The results from this study should be available next year,” Upton wrote.

Need a little more Bluntness in your life? Check out our YouTube page! 

The Latest

Giphy of Rodney Dangerfield stretching and experiencing back-pain, in an exaggerated/funny manner
Wellness

CBD & THC for Athletes

Jack Herer: The Legendary Daytime Strain
Wellness

Jack Herer: Cannabis Royalty

OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
News

NY Revokes License in Rent-a-License Scam

OG Kush: The West Coast Legend
Wellness

OG Kush: West Coast Classic

More For You

Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
a crudely rolled lit joint being passed to camera
Photo by Chase Fade on Unsplash

Alcohol vs Marijuana: Alcohol Worse?

Turns out, your friend who swapped tequila shots for THC gummies might be on to something. A new poll has found that a majority of Americans now believe alcohol is more harmful to a person’s health than marijuana—and frankly, it’s about time. The severe health risks associated with alcohol use, including addiction, various diseases, and a high incidence of mortality, are becoming more widely recognized.

The survey, conducted by YouGov, asked over 1,000 U.S. adults to weigh in on which substance does more damage: good ol’ booze or that plant that’s still somehow federally illegal. The verdict? 64% of respondents said alcohol is more dangerous, compared to just 27% who pointed the finger at weed. The rest? They couldn’t decide or didn’t care enough to pick.

Keep ReadingShow less
Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Hall of Flowers NYC Debut: Cali Vibes Minus the Pulse of NY Cannabis

Photo courtesy of Hall of Flowers

Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Upon entering through the doors at Pier 36 it was refreshing to see row after row of identical booths, neat as a spreadsheet, designed to let the product speak for itself. Buyers drifted through the aisles with line sheets instead of selfie sticks, the volume dialed way down compared to last month's Revelry event at the same location. And, maybe that was the point. Hall of Flowers’ first New York edition was designed for commerce, not commotion: a buyers-only opening day, tight credentialing, a controlled environment and pace that favored real conversations over spectacle.

The uniformity of Hall of Flowers' format erased the booth-flex arms race; most of the brands stood shoulder-to-shoulder on product, pricing, and execution. “Much easier to have conversations here than at Revelry,” several attendees told us. Others called it “weak” or “quiet” by comparison. One marketing exec involved in the event went all in saying, “Revelry is a flea market compared to Hall of Flowers.” What he meant by that is: Hall of Flowers is a curated, high-end trade event, whereas Revelry functions more as a community marketplace. I could see his point.

Keep ReadingShow less
Diverse mix of people sitting outdoors, around a table smiling at camera
Hall of Flowers 2025: Why This Santa Rosa Showcase Remains a Standard Bearer for Cannabis Trade Shows
Press photo provided by Hall of Flowers

Hall of Flowers 2025: Cannabis Trade Show Leader

The cannabis industry has no shortage of events, but very few manage to balance business, culture, and community the way Hall of Flowers does. Since its launch in 2018, the Santa Rosa-based show has become a must-attend gathering for licensed brands, retailers, investors, and innovators.

This year’s edition takes place September 10–11, 2025, at the Sonoma County Fairgrounds, continuing a legacy that goes far beyond trade show floor traffic. Hall of Flowers has become a barometer for where cannabis is now and where it's heading—and how brands and buyers can stay ahead of the curve.

Keep ReadingShow less